Key result
Diuretics remain essential for managing hypertension and hypervolemia, with data showing chlorthalidone lowers cardiovascular events by one-fifth compared to hydrochlorothiazide.
Why the study?
Do diuretics reduce cardiovascular events and mortality in patients with hypertension and heart failure?
Do diuretics reduce cardiovascular events and mortality in patients with hypertension and heart failure?
Diuretics remain a diverse and highly effective class of medications for reducing cardiovascular events and mortality in hypertension and heart failure.
Answers are grounded in this paper and cite their sources.
Supports diuretic use in hypertension and HF; leaves open optimal agent selection in prospective trials.
Diuretics have been recommended as first-line treatment of hypertension and are also valuable in the management of hypervolemia and electrolyte disorders. This review summarizes the key features of the most commonly used diuretics. We then provide an update of clinical trials for diuretics during the past 5 years. Compared to other classes of medications, thiazide diuretics are at least as effective in reducing cardiovascular events (CVEs) in patients with hypertension and are more effective than β-blockers and angiotensin-converting enzyme inhibitors in reducing stroke. Observational cohort data and a network analysis have shown that CVEs are lowered by one-fifth from chlorthalidone when compared to the commonly used thiazide, hydrochlorothiazide. Relative to placebo, chlorthalidone increases life expectancy. In those aged 80 years and older, the diuretic, indapamide, lowers CVEs relative to placebo. The aldosterone antagonist, eplerenone, lowers total mortality in early congestive heart failure. The benefit of eplerenone following acute myocardial infarction (MI) is limited to administration within 3 to 6 days post-MI. Aldosterone antagonists have been shown to lower the incidence of sudden cardiac death and to reduce proteinuria. In the setting of heart failure, long acting loop diuretics azosemide and torasemide are more effective in improving heart failure outcomes than the far more commonly used short acting furosemide. Evening dosing of diuretics appears to lower CVEs relative to morning dosing. In conclusion, diuretics are a diverse class of drugs that remain extremely important in the management of hypertension and hypervolemic states.
No takes yet. Share an insight, caveat, or question.
Roush et al. (2013) conducted a review in Hypertension, hypervolemia, and electrolyte disorders. Diuretics vs. Placebo, other antihypertensives, or other diuretics was evaluated. Diuretics remain essential for managing hypertension and hypervolemia, with data showing chlorthalidone lowers cardiovascular events by one-fifth compared to hydrochlorothiazide.
Synapse has enriched 10 related papers. Consider them for comparative context: